Clinical implication of 14-3-3 epsilon expression in gastric cancer (2012)
Source: World Journal of Gastroenterology. Unidade: FM
Subjects: NEOPLASIAS GÁSTRICAS (GENÉTICA;IMUNOLOGIA), WESTERN BLOTTING, EXPRESSÃO GÊNICA, PROTEÍNAS PROTO-ONCOGÊNICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, v. 18, n. 13, p. 1531-1537, 2012Tradução . . Disponível em: https://doi.org/10.3748/wjg.v18.i13.1531. Acesso em: 27 ago. 2024.APA
Leal, M. F., Calcagno, D. Q., Demachki, S., Assumpção, P. P., Chammas, R., Burbano, R. R., & Smith, M. de A. C. (2012). Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, 18( 13), 1531-1537. doi:10.3748/wjg.v18.i13.1531NLM
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 ago. 27 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531Vancouver
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 ago. 27 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531
